RT Journal Article
SR Electronic
T1 634 EVEREST-1: A seamless phase 1/2 study of CEA logic-gated Tmod CAR T-cell therapy (A2B530) in patients with solid tumors associated with CEA expression also exhibiting HLA loss of heterozygosity (LOH)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A724
OP A725
DO 10.1136/jitc-2023-SITC2023.0634
VO 11
IS Suppl 1
A1 Punekar, Salman R
A1 Welling, Theodore
A1 Randolph Hecht, J
A1 Molina, Julian
A1 Smith, Caleb
A1 Garon, Edward
A1 Pia Morelli, M
A1 Fakih, Marwan
A1 Kirtane, Kedar
A1 Grierson, Patrick M
A1 Patel, Sandip P
A1 Lin, Yi
A1 Kopetz, Scott
A1 Locke, Frederick L
A1 Ward, Jeffrey
A1 Lozac’hmeur, Ariane
A1 Frigault, Matthew
A1 Nikiforow, Sarah
A1 Weng, Wen-Kai
A1 Specht, Jennifer
A1 Dragovich, Tomislav
A1 Vong, Judy
A1 Mardiros, Armen
A1 Liechty, Kirstin
A1 Go, William Y
A1 Welch, John
A1 Ng, Eric W
A1 Maus, Marcela
A1 Maloney, David
A1 Simeone, Diane M
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A724.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.